AU3699000A - Use of protein conformation for the protection and release of chemical compounds - Google Patents

Use of protein conformation for the protection and release of chemical compounds

Info

Publication number
AU3699000A
AU3699000A AU36990/00A AU3699000A AU3699000A AU 3699000 A AU3699000 A AU 3699000A AU 36990/00 A AU36990/00 A AU 36990/00A AU 3699000 A AU3699000 A AU 3699000A AU 3699000 A AU3699000 A AU 3699000A
Authority
AU
Australia
Prior art keywords
release
protection
chemical compounds
protein conformation
conformation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36990/00A
Inventor
Randal J. Kirk
Keith R. Latham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lotus Biochemical Corp
Original Assignee
Lotus Biochemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lotus Biochemical Corp filed Critical Lotus Biochemical Corp
Publication of AU3699000A publication Critical patent/AU3699000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychology (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyamides (AREA)
AU36990/00A 1999-03-10 2000-03-10 Use of protein conformation for the protection and release of chemical compounds Abandoned AU3699000A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US26541599A 1999-03-10 1999-03-10
US09265415 1999-03-10
US41123899A 1999-10-04 1999-10-04
US09411238 1999-10-04
PCT/US2000/003717 WO2000053233A1 (en) 1999-03-10 2000-03-10 Use of protein conformation for the protection and release of chemical compounds

Publications (1)

Publication Number Publication Date
AU3699000A true AU3699000A (en) 2000-09-28

Family

ID=26951196

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36990/00A Abandoned AU3699000A (en) 1999-03-10 2000-03-10 Use of protein conformation for the protection and release of chemical compounds

Country Status (3)

Country Link
JP (1) JP2002540073A (en)
AU (1) AU3699000A (en)
WO (1) WO2000053233A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716452B1 (en) 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US7067111B1 (en) 1999-10-25 2006-06-27 Board Of Regents, University Of Texas System Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
JP2004523480A (en) * 2000-08-22 2004-08-05 ニュー リバー ファーマシューティカルズ， インコーポレイテッド Active agent delivery systems and methods of protecting and administering active agents
JP2006516947A (en) * 2000-11-16 2006-07-13 ニュー リバー ファーマシューティカルズ インコーポレイテッド Novel pharmaceutical compound and method for producing and using the same
US7261875B2 (en) 2001-12-21 2007-08-28 Board Of Regents, The University Of Texas System Dendritic poly (amino acid) carriers and methods of use
IL163668A0 (en) * 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Use of peptide-drug conjugation to reduce inter-subject variability ofdrug serum levels
KR100822498B1 (en) * 2002-02-22 2008-04-16 샤이어 엘엘씨 Novel Sustained Release Pharmaceutical Compounds to Prevent Abuse of Controlled Substances
KR20040088519A (en) * 2002-02-22 2004-10-16 뉴 리버 파마슈티칼스, 인크. Active Agent Delivery Systems and Methods for Protecting and Administering Active Agents
US9050378B2 (en) 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
JP5371746B2 (en) * 2006-05-26 2013-12-18 ファーマコフォア， インコーポレイテッド Controlled release of phenolic opioids
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
JP6262334B2 (en) * 2013-04-26 2018-01-17 日東電工株式会社 Large scale method for producing poly (glutamyl-glutamate) conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224316A (en) * 1979-03-30 1980-09-23 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
DE69633018T2 (en) * 1995-11-14 2004-12-09 Abbott Gmbh & Co. Kg Thyroid hormone-containing medicinal products and method

Also Published As

Publication number Publication date
JP2002540073A (en) 2002-11-26
WO2000053233A1 (en) 2000-09-14

Similar Documents

Publication Publication Date Title
AUPP913999A0 (en) Novel chemical compounds and their use
AU763356C (en) Fused-ring compounds and use thereof as drugs
AU6865298A (en) The use of cryoprotective agent compounds during cryosurgery
AU3951699A (en) The use of an anti-microbial compound for disinfection
HUP0102556A3 (en) Benzenesulfonamide-derivatives and their use as medicaments and process for the preparation of the compounds
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU782631C (en) Novel heterocyclic compounds and salts thereof and medicinal use of the same
AU6062498A (en) Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use
AU3699000A (en) Use of protein conformation for the protection and release of chemical compounds
AU4213299A (en) Controlled release of substances
AU2575201A (en) Use of hsp27 as an anti-inflammatory agent
HUP0203611A3 (en) 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU1569501A (en) Beta-aminoacid compounds useful for inhibiting beta-amyloid peptide release and/or its synthesis
AU2021601A (en) Composition for the treatment of dandruff
GB9929702D0 (en) Chemical compounds and their uses
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AU2998700A (en) Organosilicon compounds and uses thereof
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
AU2829700A (en) Processes for the preparation of alpha-aminoketones
AU2691200A (en) Isoxazoline compounds and processes for the preparation thereof
AU2565900A (en) Mixtures of materials
AU4450100A (en) 225Ac-heha and related compounds, methods of synthesis and methods of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase